Your Molecule matters
A continuum of small to large scale Custom API capabilities
As a Global CDMO we support at every stage of the product lifecycle.
With 25 years of experience in process development, scale-up and ongoing cGMP manufacturing of small molecule APIs, we support emerging, specialty and large pharmaceutical customers for their drug substance or drug delivery needs.Discover
Highly efficient cGMP manufacturing capabilities
As a fully integrated CDMO, Seqens is uniquely positioned to address the continuum of the API value chain : API, HPAPI, cGMP & non-GMP intermediates, RSM, controlled substances, excipient for drug deliveryDiscover
A trusted supplier
of proprietary APIs
More than 50 APIs have been successfully launched in the United States, Europe and Japan with consistently superior quality, reliability and customer service, supported by regulatory documentation to meet the most stringent standards from local agenciesDiscover
A continuum of custom synthesis technologies
8 industrial plants and 3 R&D centers in Europe, North America and Asia.
More than 300 scientists, engineers and experts develop tailor-made solutions for its customers and ensure that products are successfully transferred into production.
SEQENS is committed to the development and production of critical molecules in France
A new large scale potent API manufacturing unit at SEQENS Villeneuve-La-Garenne
Lahr's Site: a Seqens CDMO plant.
API lifecycle management: A CDMO perspective
Seqens CDMO global presenceUse interactive map
6 cGMP/FDA inspected sites in EU & US
Pre-GMP sites for RSMs & Intermediates
DMFs for commercial APIs
Scientists, experts and engineers
R&D centers in UE and US